· News

P+P advised Dermapharm Holding SE on acquisition of Merck subsidiary Allergopharma

P+P Pöllath + Partners advised Dermapharm Holding SE on the acquisition of Allergopharma GmbH & Co. KG, a subsidiary of Merck KGaA, headquartered in Reinbek bei Hamburg. Through Dermapharm Beteiligungs GmbH, the company has acquired 100% of the shares in the Merck subsidiary.

The transaction is still subject to the approval of the relevant regulatory authorities; the transaction is expected to close at the end of the second quarter 2020.

Dermapharm Holding SE is headquartered in Grünwald and focuses on the manufacture and distribution of high-quality dermatological and allergological pharmaceutical products. Allergopharma specializes in desensitization for allergies.

P+P Pöllath + Partners advised Dermapharm Holding SE on all legal matters related to the acquisition with the following team that specializes in various practice areas across all offices:

Press contact